better
understand
diseas
associ
biomark
could
potenti
start
new
area
uncov
mechan
cancer
progress
develop
offer
better
target
drug
develop
studi
singl
geneproteinmetabolit
molecular
signatur
offer
limit
insight
complex
interplay
among
molecul
respons
progress
complex
diseas
cancer
thu
shift
toward
identif
panel
gene
interact
directli
indirectli
form
pathway
complex
network
evalu
associ
cancer
accomplish
massiv
data
deriv
high
throughput
omic
technolog
next
gener
sequenc
microarray
mass
spectrometri
although
thousand
candid
biomark
discov
technolog
transfer
practic
applic
clinic
set
new
drug
product
challeng
lie
high
fals
posit
rate
candid
biomark
identifi
omic
data
lack
attent
studi
context
biomark
interact
form
pathway
network
associ
cancer
fragment
incomplet
inform
base
biomark
identifi
sole
omic
platform
lack
effect
algorithm
allow
integr
divers
omic
data
sourc
simul
biolog
pathway
network
meet
challeng
number
pathway
network
base
approach
introduc
review
articl
evalu
advantag
limit
method
tradit
approach
individu
panel
cancer
biomark
select
analyt
method
analysi
varianc
anova
lasso
pairwis
inform
theori
support
vector
machin
svm
explicitli
consid
interact
gene
protein
metabolit
compar
tradit
method
pathway
network
centric
method
natur
provid
way
understand
underli
pathway
interact
individu
signatur
marker
nonmark
largescal
gener
integr
genom
transcriptom
proteom
metabolom
data
pathwaynetworkbas
method
provid
effect
accur
mean
cancer
biomark
discoveri
increasingli
pathway
networkbas
analys
appli
omic
data
gain
insight
underli
biolog
function
process
cell
signal
metabol
pathway
well
gene
regulatori
network
number
pathway
network
approach
also
use
improv
predict
cancer
outcom
provid
novel
hypothes
pathway
involv
tumor
progress
explor
cancer
associ
biomark
exampl
taylor
et
al
combin
gene
express
data
physic
proteinprotein
interact
data
identifi
subnetwork
marker
prognosi
breast
cancer
lymphoma
patient
torkamani
schork
use
gene
coexpress
network
infer
canceriniti
gene
breast
colorect
cancer
glioblastoma
kim
et
al
appli
mapit
multi
analyt
pathway
infer
tool
algorithm
identifi
prognost
network
marker
predict
gbm
patient
surviv
time
use
multianalyt
network
marker
discov
integr
gene
express
profil
epigenom
profil
proteinprotein
interactom
goh
et
al
built
human
diseas
network
hdn
link
hereditari
diseas
share
diseasecaus
gene
record
mendelian
inherit
man
omim
databas
although
function
connect
hdn
remain
demonstr
inspir
us
systemat
studi
relationship
among
diseas
construct
network
detail
descript
relationship
human
diseas
network
essenti
understand
human
recent
summar
review
review
provid
pathway
network
centric
comput
approach
applic
biomark
discoveri
statist
method
test
scientif
theori
observ
process
boundari
condit
subject
stochast
exampl
classic
ttest
extens
use
test
differenti
gene
express
microarray
data
howev
kind
procedur
reli
reason
estim
reproduc
withingen
error
requir
larg
number
replic
array
thu
sever
method
improv
estim
variabl
statist
test
differenti
express
propos
exampl
signific
analysi
microarray
sam
aim
improv
unstabl
error
estim
twosampl
ttest
ad
varianc
stabil
factor
minim
varianc
variabl
across
differ
intens
rang
anova
model
approach
wide
use
multipl
kind
omic
data
exampl
use
model
microarray
data
effect
array
condit
conditionarray
interact
fit
residu
effect
gene
genecondit
interact
genearray
interact
also
appli
captur
effect
control
group
batch
condit
alia
experiment
equip
conditionmetabolit
interact
separ
lcm
data
improv
accuraci
sensit
analyt
result
fals
discoveri
rate
fdr
refin
qvalu
qvalu
packag
wwwbioconductororg
rapidli
adopt
genom
proteom
metabol
data
analysi
includ
widelyus
sam
david
approach
anoth
statist
method
biomark
discoveri
linear
discrimin
analysi
lda
one
classic
statist
classif
techniqu
base
multivari
normal
distribut
assumpt
quit
robust
power
discov
biomark
pathway
omic
data
mani
differ
applic
despit
distribut
assumpt
compar
lda
quadrat
discrimin
analysi
qda
requir
observ
estim
variancecovari
matrix
class
addit
logist
regress
analysi
success
use
evalu
biomark
perform
prostat
cancer
mrna
profil
logist
regress
lr
model
base
regress
fit
probabilist
odd
compar
condit
requir
specif
distribut
assumpt
eg
gaussian
distribut
often
found
less
sensit
model
fundament
graph
theori
often
use
describ
global
topolog
structur
commun
complex
system
emphas
entiti
eg
gene
protein
diseas
biolog
process
relat
complex
graphic
model
either
simpl
node
edg
complex
edg
weight
node
edg
differ
type
recent
public
appli
graphic
model
comput
biolog
studi
biolog
network
enhanc
abil
draw
causal
infer
function
mri
experi
support
earli
detect
disconnect
model
patholog
spread
neurodegen
diseas
alzheim
diseas
exampl
mammalian
cell
bleri
et
al
earli
success
character
dynam
key
feed
forward
modul
motif
help
enabl
circuit
design
adapt
gene
express
use
graph
base
approach
maayan
et
al
model
cellular
machineri
includ
gene
protein
subcellular
compart
interact
compon
drawn
edg
connect
relev
node
gene
express
data
combin
network
analysi
yield
import
inform
express
variat
relat
differ
observ
state
close
connect
gene
tend
involv
similar
function
network
annot
complement
cluster
obtain
via
fold
chang
analysi
standard
systemsbas
approach
biomark
drug
target
discoveri
consist
place
put
known
biomark
context
network
biolog
interact
follow
differ
guiltbyassoci
analys
goal
visual
find
pattern
structur
remain
hidden
raw
unstructur
dataset
graph
visual
key
display
directli
variou
relationship
entiti
eg
gene
protein
challeng
graph
visual
lie
high
fals
posit
rate
incorpor
heterogen
multiom
dataset
visual
represent
logic
structur
transform
raw
data
graph
manipul
layout
algorithm
repres
complic
relationship
biolog
entiti
heterogen
omic
data
differ
level
visual
need
flexibl
layer
represent
number
commerci
free
sourc
graph
visual
tool
platform
extens
develop
exampl
cytoscap
one
free
open
sourc
platform
provid
biolog
network
analysi
visual
regist
plugin
contribut
commun
versatil
network
applic
network
import
network
integr
infer
custom
literatur
mine
topolog
cluster
function
enrich
network
comparison
programmat
access
cytoscap
plugin
provid
threedimension
dynam
parallel
network
visual
mass
spectrometri
ms
molecular
network
ipa
commerci
softwar
tool
pathway
analysi
omic
data
provid
power
graphic
visual
pathway
network
overlaid
diseas
drug
biolog
process
etc
pathwaystudio
provid
abstract
graphic
interfac
user
analyz
gene
express
protein
interact
metabol
data
analyz
explor
pathway
network
identifi
data
string
give
graphic
visual
protein
interact
known
predict
also
quantifi
pair
protein
interact
type
physic
interact
gene
fusion
etc
bayesian
method
allow
inform
prior
prior
knowledg
result
previou
model
use
inform
current
model
cancer
bioinformat
system
biolog
primari
applic
bayesian
method
includ
bayesian
infer
bayesian
network
naiv
bay
classifi
bayesian
variabl
select
among
method
bayesian
network
one
common
model
tool
pathway
network
analysi
bayesian
network
form
direct
statist
model
design
captur
condit
depend
probabilist
event
consist
depend
structur
local
probabl
model
also
name
probabilist
graph
model
includ
hierarch
bayesian
network
hbn
probabilist
boolean
network
pbn
hidden
markov
model
hmm
markov
logic
network
mln
depend
structur
specifi
variabl
relat
draw
direct
edg
variabl
without
creat
direct
cycl
variabl
depend
possibl
set
variabl
term
parent
compar
pathwaynetwork
centric
method
bayesian
network
model
capabl
integr
heterogen
data
miss
valu
depend
relationship
variabl
bayesian
network
model
probabl
defin
relationship
current
node
predecessor
parent
graph
power
method
lie
abil
facilit
revers
engin
multiplex
network
base
molecular
express
molecular
activ
andor
cell
behavior
data
serv
precursor
synthet
modif
exist
molecular
pathway
bayesian
infer
one
import
bayesian
method
wide
use
cancer
biomark
discoveri
signal
pathway
network
infer
previous
appli
gene
express
data
infer
gene
regulatori
network
infer
protein
signal
network
gene
regulatori
network
incorpor
explicit
time
element
dynam
bayesian
infer
propos
interrog
dynam
signal
respons
within
bayesian
framework
exist
signal
biolog
incorpor
inform
prior
distribut
network
addit
bayesian
variabl
select
aim
solv
problem
larg
p
small
n
exist
omic
data
set
use
prior
knowledg
pathway
protein
interact
estim
posterior
probabl
markov
chain
mont
carlo
mcmc
also
wide
use
infer
function
interact
biochem
pathway
model
interact
differ
function
modul
biolog
network
pathway
base
cancer
biomark
discoveri
exampl
yang
et
al
use
bayesian
network
construct
hcc
cell
network
identifi
function
modul
interact
modul
stochast
simul
model
offer
altern
hitherto
associ
major
disadvantag
likelihood
function
calcul
explicitli
thu
difficult
coupl
wellestablish
statist
theori
maximum
likelihood
bayesian
statist
number
new
method
among
approxim
bayesian
comput
patternori
model
bypass
limit
differ
bayesian
frequentist
infer
lie
follow
bayesian
infer
provid
answer
condit
observ
data
base
distribut
estim
test
statist
imaginari
sampl
observ
rossi
et
al
p
includ
uncertainti
probabl
model
yield
realist
predict
safeguard
overfit
integr
model
paramet
qualiti
prior
inform
directli
impact
perform
bayesian
method
also
unabl
account
feed
back
regul
hallmark
signal
network
growth
inform
literatur
biomed
databas
biolog
clinic
scientist
need
effici
mean
handl
extract
diagnost
method
prognost
term
inform
scientif
literatur
purpos
text
mine
compris
discoveri
extract
knowledg
free
text
gener
new
hypothes
particularli
relev
help
biomed
research
text
mine
complement
read
scientif
literatur
individu
research
allow
rapid
access
inform
contain
larg
volum
document
increas
reproduc
literatur
search
enabl
user
process
document
specif
result
primari
applic
textmin
biomed
research
roughli
lie
three
aspect
simpl
textmin
transform
textual
inform
databas
content
integr
exist
knowledg
resourc
suggest
novel
hypothes
literatur
analysi
includ
cluster
classif
entiti
diseas
integr
biolog
produc
test
hypothes
knowledg
base
current
text
mine
success
appli
identif
molecular
caus
diseas
use
fact
databas
literatur
exampl
textmin
use
suggest
diseas
biomark
scientif
literatur
made
basi
assumpt
two
protein
like
interact
share
substanti
amount
contextu
inform
defin
gene
interest
network
construct
scientif
public
relat
querydefin
gene
result
brows
navig
visual
network
copub
make
use
lexic
resourc
gene
protein
gene
ontolog
label
diseas
pathway
drug
tissu
identifi
statist
qualifi
signific
specif
term
gene
set
gene
result
return
set
annot
gene
interest
besid
text
mine
wide
use
industri
larg
scale
knowledg
base
queri
gene
protein
metabol
compound
drug
function
analysi
visual
knowledg
contain
scientif
literatur
softwar
tool
develop
provid
improv
integr
textmin
result
data
resourc
exampl
ipa
ingenu
kegg
pathway
studio
hprd
use
textmin
integr
geneproteinphenotyp
associ
link
gene
protein
variant
diseas
toxic
effect
drug
respons
knowledg
databas
depend
task
research
address
textmin
achiev
differ
object
includ
primarili
follow
retriev
inform
relev
document
identif
entiti
gene
diseas
complex
relationship
entiti
diseas
interact
protein
gene
deposit
extract
inform
databas
use
support
manual
databas
curat
effort
gener
hypothesi
test
novel
research
question
trend
textmin
techniqu
shift
analysi
abstract
full
text
paper
analysi
gene
proteinrel
inform
inform
cell
tissu
whole
organ
promin
shift
integr
inform
literatur
data
set
domain
gene
express
profil
genomewid
associ
studi
gwass
biochemistri
phenotyp
textmin
prone
integr
machin
learn
statist
techniqu
futur
textmin
might
face
sever
major
challeng
improv
literatur
analysi
integr
exist
knowledg
base
visual
extract
inform
machin
learn
method
use
biomark
discoveri
highthroughput
omic
data
infer
causal
relat
mutat
diseas
interact
gene
protein
relat
environment
featur
cancer
well
pathway
network
model
two
kind
basic
machin
learn
techniqu
one
unsupervis
machin
learn
hierarch
cluster
selforgan
map
som
etc
supervis
machin
learn
need
known
knowledg
data
train
model
appli
model
predict
output
variabl
number
machin
learn
svm
artifici
neural
network
decis
tree
random
forest
rf
etc
wide
variou
applic
includ
identif
breast
cancer
biomark
diagnosi
biomark
parkinson
disord
subcellular
locat
protein
predict
protein
function
basi
protein
structur
annot
mutat
exampl
han
propos
machin
learn
base
deriv
compon
analysi
method
select
implicit
featur
captur
subtl
data
behavior
remov
system
nois
proteom
profil
overcom
reproduc
problem
biomark
discoveri
proteom
anoth
interest
studi
hoshida
et
al
combin
eight
independ
cohort
gene
express
profil
reveal
subclass
hcc
relat
pathway
use
unsupervis
machin
learn
method
found
three
common
subclass
hepatocellular
carcinoma
hcc
significantli
correl
wnt
pathway
myc
akt
hepatocyt
differenti
respect
westen
blot
knockout
immunohistochem
stain
use
experiment
valid
discoveri
anoth
framework
call
knowledgedriven
matrix
factor
kmf
propos
yang
et
al
use
reconstruct
phenotypespecif
modular
gene
network
integr
data
multipl
omic
studi
help
unravel
underli
molecular
mechan
carcinogenesi
also
identifi
signatur
signal
pathwaynetwork
characterist
specif
cancer
type
use
diagnosi
prognosi
guidanc
target
therapi
method
describ
section
ae
proven
use
discov
biomark
highthroughput
omic
data
analyz
proteinprotein
proteindna
kinasesubstr
interact
well
genet
interact
among
gene
effort
yield
good
result
cancer
biomark
discoveri
protein
interact
interact
genotyp
diseas
howev
current
omic
technolog
provid
limit
fragment
realiti
biolog
function
within
cell
cancer
mechan
separ
analysi
data
gener
technolog
limit
reveal
partial
aberr
molecular
chang
interact
multipl
molecul
model
isol
analysi
gene
protein
metabolit
furthermor
limit
intrins
high
nois
incomplet
data
small
samples
bia
motiv
use
integr
omic
analysi
use
prior
biolog
knowledg
inform
base
rather
mere
collect
singl
largescal
omic
studi
howev
integr
multipl
dispar
data
type
remain
signific
challeng
system
biolog
research
recent
attempt
integr
multipl
highthroughput
omic
data
concentr
captur
regulatori
associ
gene
protein
compar
express
pattern
across
multipl
condit
combin
function
character
quantit
evid
extract
differ
data
sourc
level
gene
product
mrna
protein
metabolit
well
interact
previou
work
integr
analysi
util
pathway
form
connect
rout
graphbas
represent
metabol
network
approach
focu
function
modul
protein
interact
network
analyz
experiment
data
context
pathway
use
multipl
sourc
omic
data
other
develop
advanc
bioinformat
tool
algorithm
facilit
integr
divers
data
type
differ
biolog
type
data
sequenc
protein
structur
famili
proteom
data
ontolog
gene
express
experiment
data
set
show
grow
complex
produc
numer
heterogen
applic
area
integr
heterogen
data
therefor
becom
import
order
gain
insight
complex
dynam
biolog
system
inform
store
data
repositori
need
link
combin
effici
way
hepatocellular
carcinoma
hcc
fifth
common
malign
third
lead
caus
cancer
death
world
fiveyear
surviv
rate
approach
treatment
hcc
includ
surgic
resect
transplant
ablat
transarteri
chemoembol
system
chemotherapi
even
exist
system
chemotherapi
effect
advanc
hcc
exampl
lovet
et
al
report
target
therapi
sorafenib
inhibit
multipl
tyrosin
kinas
receptor
rasvegfr
may
prolong
surviv
three
month
howev
due
redund
compens
signal
network
hcc
signific
reorgan
signal
network
observ
regul
tumor
suppressor
xiap
silenc
prb
silenc
upregul
tumor
promot
protein
xiap
silenc
pcreb
silenc
may
confer
growth
benefit
cancer
cell
exampl
suggest
provid
pathway
network
inform
may
improv
efficaci
system
chemotherapi
hcc
chang
et
al
partit
complex
oncogen
signal
network
basic
unit
function
modul
signal
activ
eg
protein
phosphoryl
anoth
protein
activ
kinas
activ
demonstr
gene
express
signatur
base
modul
predict
effect
pathwayspecif
therapeut
except
surgic
resectiontransplant
earli
stage
hcc
surviv
time
significantli
prolong
treatment
ad
pathway
network
centric
method
make
use
omic
data
systemat
chemotherapi
benefit
develop
newer
therapeut
target
hcc
treatment
recent
year
comput
method
model
take
import
role
hcc
investig
comput
system
also
develop
exampl
shannon
et
al
develop
java
base
tool
gaggl
integr
divers
databas
eg
kegg
biocyc
string
softwar
eg
cytoscap
r
simultan
explor
experiment
data
eg
mrna
protein
abund
proteinprotein
proteindna
interact
function
associ
metabol
pathway
kegg
pubm
abstract
recent
zheng
et
al
identifi
molecular
event
underli
develop
hcv
induc
hcc
integr
gene
express
profil
protein
interact
data
get
subnetwork
refin
network
remov
network
compon
number
node
smaller
five
found
four
subnetwork
call
normalcirrhosi
cirrhosisdysplasia
dysplasiaearli
earlyadvanc
hcc
network
sub
network
identifi
function
modul
hub
gene
compar
pathway
sub
network
observ
chang
pathway
network
activ
find
valid
literatur
even
though
type
omic
data
use
includ
gene
express
protein
interact
provid
way
studi
chang
network
activ
analysi
omic
data
zhang
et
al
use
systemat
method
includ
partial
least
squar
literatur
mine
techniqu
genego
metacor
discov
biomark
hcc
gene
express
well
protein
data
base
marker
gene
construct
regul
regul
network
former
identifi
regul
hub
gene
identifi
hub
gene
fo
junb
egfr
latter
partial
least
squar
employ
construct
classifi
biomark
use
fivefold
crossvalid
two
independ
dataset
evalu
perform
classifi
furthermor
use
experiment
immunohistochemistri
western
blot
measur
verifi
marker
gene
predict
classifi
result
show
networkbas
approach
facilit
biomark
identif
improv
classif
accuraci
hollywod
et
al
identifi
driver
gene
potent
diagnosi
marker
mechan
studi
hcc
use
tstatist
map
tm
transcriptom
correl
map
tcm
approach
integr
dna
copi
number
measur
genom
cgh
array
gene
express
found
driver
gene
signific
prognost
relev
hcc
key
signal
pathway
mtor
ampk
egfr
sirnamedi
knockdown
experi
use
evalu
function
signific
driver
gene
even
though
collect
divers
omic
data
analyz
relationship
hcc
phenotyp
biolog
entiti
within
cell
prove
power
enough
integr
still
fragmentari
incomplet
inadequ
reflect
whole
pictur
cancer
inform
develop
amount
omic
data
genom
proteom
metabolom
interactom
increas
pace
explos
omic
data
number
openaccess
databas
contain
comprehens
gene
protein
interact
biolog
pathway
network
inform
develop
provid
biologist
valuabl
tool
analyz
data
complex
biolog
system
includ
intact
biogrid
mint
kegg
pid
string
reactom
etc
provid
use
qualit
map
function
associ
key
compon
canon
pathway
tabl
summar
primari
data
sourc
url
specif
hcc
wide
applic
omic
techniqu
accur
ubiquit
biomark
identifi
brought
clinic
set
mani
prove
irreproduc
one
concern
biomark
identifi
suffer
low
diagnost
specif
sensit
lead
current
cancer
biomark
yet
made
major
impact
reduc
cancer
burden
instanc
serum
alphafetoprotein
afp
wide
use
biomark
detect
monitor
hcc
fals
neg
rate
afp
level
may
high
patient
earli
stage
hcc
advanc
patient
afp
level
remain
small
patient
one
import
limit
possibl
artifact
conduc
biolog
experi
instrument
variabl
other
includ
bia
sampl
collect
sampl
handl
lead
cohort
differ
exampl
sreekumar
et
al
report
sarcosin
prostat
cancer
biomark
metabolom
analysi
howev
subsequ
valid
studi
done
jentzmik
et
al
conclud
level
sarcosin
measur
gcm
could
differenti
malign
nonmalign
tissu
collestelli
et
al
report
statist
signific
differ
prostat
cancer
healthi
control
sarcosin
creatinin
ratio
level
sarcosin
higher
healthi
control
anoth
import
limit
relat
lack
comput
method
extract
knowledg
omic
data
involv
substanti
amount
nois
high
dimension
miss
valu
etc
although
use
pathway
networkbas
approach
integr
prior
biolog
knowledg
omic
data
promis
address
comput
challeng
limit
outlin
mrna
level
dna
alter
may
accur
reflect
correspond
protein
level
fail
reveal
chang
posttranscript
protein
modul
eg
phosphoryl
acetyl
methyl
ubiquitin
etc
protein
degrad
rate
correl
mrna
associ
protein
express
rel
low
signal
network
construct
use
approach
reflect
dynam
signal
flow
spatial
relationship
also
genom
chang
mrna
level
snp
cnv
methyl
ultim
affect
protein
express
activ
inactiv
turn
control
cellular
behaviorcurr
proteom
technolog
provid
limit
coverag
proteom
sensit
technolog
need
identifi
quantit
low
abund
protein
pathway
map
result
fact
pathway
annot
current
take
littl
consider
tissu
specif
gene
protein
pathway
limit
tissu
andor
isoform
specif
pathway
annot
thu
specif
step
pathway
may
actual
activ
tissuescel
omic
data
may
gener
case
may
occur
protein
isoform
splice
variant
annot
protein
class
canon
protein
sequenc
respect
pathway
may
express
differenti
differ
tissuescellsbecaus
biolog
pathway
inher
complex
dynam
pathway
annot
differ
pathway
databas
vari
significantli
pathway
model
number
aspect
eg
specif
protein
form
dynam
complex
format
subcellular
locat
pathway
cross
talk
current
comput
method
thu
need
provid
solut
issu
includ
reveal
pattern
within
data
model
heterogen
profil
diseas
class
subclass
produc
predict
patient
classif
etc
biomark
discoveri
chang
research
away
identif
individu
biomark
search
perturb
pathway
network
activ
earli
detect
cancer
improv
surviv
enhanc
qualiti
life
ideal
marker
would
one
measur
easili
reliabl
use
assay
high
sensit
specif
undergo
rigor
valid
introduc
routin
clinic
care
current
treatment
cancer
base
tissu
type
clinic
stage
approach
often
ineffect
due
heterogen
tumor
pathway
network
base
method
taken
import
role
analysi
highthroughput
data
pathway
network
base
method
provid
global
systemat
way
explor
relationship
biomark
interact
partner
thu
futur
work
like
focu
use
pathway
network
base
method
biomark
discoveri
expect
method
discuss
becom
compon
share
infrastructur
biomed
resourc
use
research
identifi
retriev
relev
work
formul
hypothesi
find
support
contradict
evid
hypothes
integr
research
result
framework
whole
biolog
system
support
translat
research
result
across
domain
clinic
applic
